Global Yang Xie Dang Gui Tang Jiang Market Growth 2024-2030

Global Yang Xie Dang Gui Tang Jiang Market Growth 2024-2030

Product Code:1240232

Published Date: Nov 22,2024

Pages: 135

Region: Global

Category: Pharma & Healthcare

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

The global Yang Xie Dang Gui Tang Jiang market size is predicted to grow from US$ 91.1 million in 2024 to US$ 126 million in 2030; it is expected to grow at a CAGR of 5.6% from 2024 to 2030.

Yang Xie Dang Gui Tang Jiang is a traditional Chinese medicine preparation, mainly used to nourish blood, regulate menstruation and improve blood circulation. It uses Angelica as the main herbal medicine, combined with other Chinese herbal medicines that have the effect of nourishing blood and activating blood circulation, and is made into a syrupy liquid after being boiled. Blood-nourishing Angelica Syrup is often used in traditional Chinese medicine to treat symptoms caused by blood deficiency, such as pale complexion, dizziness, irregular menstruation, dysmenorrhea, etc.

United States market for Yang Xie Dang Gui Tang Jiang is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Yang Xie Dang Gui Tang Jiang is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Yang Xie Dang Gui Tang Jiang is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Yang Xie Dang Gui Tang Jiang players cover Beijing Shunxin Xiangyun Pharmaceutical Co., Ltd., Guangdong Xiangshantang Pharmaceutical Co., Ltd., Jiangxi Yaodu Zhangshu Pharmaceutical Co., Ltd., Guangxi Weiwe Pharmaceutical Co., Ltd., Jiangxi Baishen Changnuo Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly 
 % in 2023.

LP Information, Inc. (LPI) ' newest research report, the “Yang Xie Dang Gui Tang Jiang Industry Forecast” looks at past sales and reviews total world Yang Xie Dang Gui Tang Jiang sales in 2023, providing a comprehensive analysis by region and market sector of projected Yang Xie Dang Gui Tang Jiang sales for 2024 through 2030. With Yang Xie Dang Gui Tang Jiang sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Yang Xie Dang Gui Tang Jiang industry.

This Insight Report provides a comprehensive analysis of the global Yang Xie Dang Gui Tang Jiang landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Yang Xie Dang Gui Tang Jiang portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Yang Xie Dang Gui Tang Jiang market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Yang Xie Dang Gui Tang Jiang and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Yang Xie Dang Gui Tang Jiang.

This report presents a comprehensive overview, market shares, and growth opportunities of Yang Xie Dang Gui Tang Jiang market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
    100ml
    120ml

Segmentation by Application:
    Hospital
    Clinic
    Other

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
    Beijing Shunxin Xiangyun Pharmaceutical Co., Ltd.
    Guangdong Xiangshantang Pharmaceutical Co., Ltd.
    Jiangxi Yaodu Zhangshu Pharmaceutical Co., Ltd.
    Guangxi Weiwe Pharmaceutical Co., Ltd.
    Jiangxi Baishen Changnuo Pharmaceutical Co., Ltd.
    Sichuan Tongyuan Pharmaceutical Group Co., Ltd.
    Jiangxi Jimin Kexin Pharmaceutical Co., Ltd.
    China Resources Sanjiu (Nanchang) Pharmaceutical Co., Ltd.
    Anguo Yadong Biopharmaceutical Co., Ltd.
    Jiangxi Xinglin Baima Pharmaceutical Co., Ltd.
    Hunan Times Sunshine Pharmaceutical Co., Ltd.
    Huichuntang Pharmaceutical Co., Ltd.
    Jiangxi Heming Pharmaceutical Co., Ltd.
    Jiangxi Shengxiang Pharmaceutical Co., Ltd.
    Chongqing Xieran Pharmaceutical Co., Ltd.
    Zhejiang Deer Pharmaceutical Co., Ltd.
    Fushoutang Pharmaceutical Co., Ltd.
    Jiangxi Dadi Pharmaceutical Co., Ltd.

Key Questions Addressed in this Report
What is the 10-year outlook for the global Yang Xie Dang Gui Tang Jiang market?
What factors are driving Yang Xie Dang Gui Tang Jiang market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Yang Xie Dang Gui Tang Jiang market opportunities vary by end market size?
How does Yang Xie Dang Gui Tang Jiang break out by Type, by Application?